Coskun Ozer Demirtas

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 11

Top Topics

Computed Tomography

Sentinel Lymph Node

Top Venues

Hepatology communications

Alimentary pharmacology & therapeutics

Hepatology forum

This page only lists publications with an associated author ORCID identifier.

Publications

Coskun Ozer Demirtas, Gabrielle Ricco, Osman Cavit Ozdogan, Feyyaz Baltacioglu, Tunc Ones, Perran Fulden Yumuk, Ender Dulundu, Sinan Uzun, Pierro Colombatto, Filippo Oliveri, Maurizia Rossana Brunetto, Feyza Gunduz
Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index. Hepatology communications 6 (12) (2022)
Coskun Ozer Demirtas, Yusuf Yilmaz
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Alimentary pharmacology & therapeutics 53 (11) (2021)
Eda Kaya, Alev Bakır Kayı, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz
Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. Gut and liver 14 (4) (2021)
Yesim Ozen Alahdab, Coskun Ozer Demirtas, Haluk Tarik Kani, Davut Tuney, Lamia Seker, Tugba Tolu, Ozlen Atug
Clinical significance of isolated abnormal intestinal findings in magnetic resonance enterography in patients with suspected small bowel disease. Abdominal radiology (New York) 45 (4) (2021)
Piero Colombatto, Coskun Ozer Demirtas, Gabriele Ricco, Luigi Civitano, Piero Boraschi, Paola Scalise, Daniela Cavallone, Filippo Oliveri, Veronica Romagnoli, Patrizia Bleve, Barbara Coco, Antonio Salvati, Lucio Urbani, Ferruccio Bonino, Maurizia Rossana Brunetto
Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. Cancers 13 (9) (2021)
Haluk Tarik Kani, Emre Tarik Sener, Umut Emre Aykut, Coskun Ozer Demirtas, Caglayan Keklikkiran, Ilkay Ergenc, Abdullah Fatih Demirci, Haydar Kamil Cam, Çiğdem Ataizi Çelikel, Cem Akbal, Deniz Guney Duman
Causes of erectile dysfunction in non-alcoholic fatty liver disease. Hepatology forum 2 (2) (2021)
Coskun Ozer Demirtas, Gabrielle Ricco, Osman Cavit Ozdogan, Feyyaz Baltacioglu, Tunc Ones, Perran Fulden Yumuk, Ender Dulundu, Sinan Uzun, Pierro Colombatto, Filippo Oliveri, Maurizia Rossana Brunetto, Feyza Gunduz
Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders. Hepatology communications (2021)
Ilkay Ergenc, Pinar Gokcen, Gupse Adali, Haluk Tarik Kani, Coskun Ozer Demirtas, Feyza Gunduz, Çiğdem Ataizi Çelikel, Yusuf Yilmaz
High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis. Hepatology forum 2 (1) (2021)
Coskun Ozer Demirtas, Caglayan Keklikkiran, Ilkay Ergenc, Buket Ertürk Sengel, Güneş Eskidemir, Ismail Cinel, Zekaver Odabaşı, Volkan Korten, Yusuf Yilmaz
Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study. International journal of clinical practice 75 (9) (2021)
Coskun Ozer Demirtas, Feyza Gunduz, Osman Cavit Ozdogan
Surveillance Strategies for Hepatocellular Carcinoma: Recent Advances and the Shifting Paradigm. Journal of gastrointestinal cancer (2021)
Coskun Ozer Demirtas, Feyza Gunduz
Letter: Is female sex an independent predictor of favourable prognosis in hepatocellular carcinoma? Alimentary pharmacology & therapeutics 52 (11-12) (2020)